| Serial Number | 90831614 |
| Word Mark | REGEN COVERED FOR REGEN-COV (CASIRIVIMAB AND IMDEVIMAB) |
| Filing Date | Thursday, July 15, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, June 6, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 7, 2021 |
| Description of Mark | The mark consists of the word "COVERED" with a stylized "V" with the word "REGEN" over the letters "COV" in the word "COVERED". Below the letters "ERED" in the word "COVERED" are the words "FOR REGEN-COV (CASIRIVIMAB AND IMDEVIMAB)" in a smaller font. The stylized "V" appears in the form of a stylized checkmark. A small horizontal oval appears as a shadow element below the "V". |
| Goods and Services | Financial administration services, namely, financial administration of a program to provide access to pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders at low or no cost to underserved populations; Financial administration services, namely, financial administration of a program to provide discounts on prescription pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders |
| Goods and Services | Business administration services, namely, business administration of a program to provide access to pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders at low or no cost to underserved populations; Business administration services, namely, business administration of a program to provide discounts on prescription pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders |
| Goods and Services | Medical and pharmaceutical consultation regarding pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders |
| Disclaimer with Predetermined Text | "CASIRIVIMAB AND IMDEVIMAB" |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 28, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 28, 2021 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 28, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Regeneron Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Tarrytown, NY 10591 |
| Party Name | Regeneron Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Tarrytown, NY 10591 |
| Event Date | Event Description |
| Monday, June 6, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, June 6, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, November 2, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 7, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 7, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 18, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, August 2, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, August 2, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, August 2, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, August 2, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Monday, August 2, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, July 28, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, July 28, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Wednesday, July 28, 2021 | PETITION TO DIRECTOR - GRANTED |
| Tuesday, July 27, 2021 | ASSIGNED TO PETITION STAFF |
| Monday, July 26, 2021 | TEAS PETITION TO DIRECTOR RECEIVED |
| Monday, July 19, 2021 | NEW APPLICATION ENTERED IN TRAM |